Statements of Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Statements of Comprehensive Loss [Abstract]
Sales	$ 2,293,313	$ 1,629,108
Cost of sales (excluding depreciation expense)	872,400	544,903
Operating expenses:
Research and development	7,577,704	8,216,543
Sales and marketing	4,443,807	4,030,150
General and administrative	6,646,037	6,325,999
Depreciation and amortization	342,034	297,318
Total operating expenses	19,009,582	18,870,010
Loss from operations	(17,588,669)	(17,785,805)
Other (expense) income:
Interest income	101,760	582,354
Change in fair value of conversion option liability	503,000	0
Change in fair value of warrants liabilities	731,000	0
Interest expense	(1,891,119)	(1,603,575)
Other expense	(482,562)	0
Total other expense, net	(1,037,921)	(1,021,221)
Loss before income taxes	(18,626,590)	(18,807,026)
Income tax expense	1,297	9,602
Net loss	(18,627,887)	(18,816,628)
Net loss attributable to common stockholders, basic	(18,627,887)	(18,816,628)
Net loss attributable to common stockholders, diluted	$ (18,627,887)	$ (18,816,628)
Net loss per share attributable to common stockholders, basic (in Dollars per share)	$ (0.47)	$ (0.85)
Net loss per share attributable to common stockholders, diluted (in Dollars per share)	$ (0.47)	$ (0.85)
Weighted-average common shares and pre-funded warrants outstanding- basic (in Shares)	39,549,218	22,267,695
Weighted-average common shares and pre-funded warrants outstanding- Diluted (in Shares)	39,549,218	22,267,695